Search
News
Opening reception of SACC - Friday 26 June 14:00-16:00

The official opening of SACC (Shared Addiction Care Copenhagen) will be launched Friday 26 June at 14.00 at the Copenhagen City Hall. Please find the program here and the press release here. Find more information about SACC here.

 

8th IAS Conference on HIV Pathogenesis, Treatment and Prevention 19-22 July 2015


Presentation:
Excess TB mortality in HIV patients in Eastern Europe: restructured approach to care needed. Presented by Anna Schultze on behalf of the TB:HIV study group in EuroCoord.
Monday 20th July 14:30-16:00. Session Title: HIV and TB: Gaps and Opportunities. Abstract number MOAB0203.

 

Implications of the START Study data

A new UNAIDS publication on the START study and the implications of its results has been released. Read the full report here.

 

BREAKING NEWS: Results of the START study

START, one of the largest ongoing HIV studies, has announced early results regarding the long-debated question of when to start HIV-infected individuals on treatment. 

Read the press release from the NIH here

Have questions about the study results and what they mean for HIV patients? Find answers on the NIH Q & A page

Go to CHIP's START news page or click on the links below to read what other news sources around the world are saying about the groundbreaking results of the START study: 

UNAIDS

The New York Times

BBC news

ScienceMag.org

Groundup.org

ibase.info

 

 

25th ECCMID, Copenhagen, Denmark, 25-28 April 2015.


Posters:

"The indications for Transplantation (TX) : a risk factor for ALT-flares and death during post-transplant follow up (FU)" . Presented by Louise Lundgren.  Authors: Louise Lundgren*, Caspar Da Cunha-Bang, Amanda Mocroft, Lars Vindeløv, Finn Gustafsson, Martin Iversen, Nikolai Kirkby, Jens Dilling Lundgren, Allan Rasmussen, Søren Schwartz Sørensen, Henrik Sengeløv – on behalf of the MATCH study group.
Saturday 25th April 15.30-16.30CET, Poster number: P0266, Poster session: Infections in Organ Transplant Recipients (P14)

Presentations:
"High Proportion of Symptomatic CMV Infection Despite Optimal Practice of a Preemptive CMV Strategy for Recipients of Solid Organ Transplantation (SOT) and Hematopoietic Stem Cell Transplantation (HSCT)"
Presented by Isabelle Lodding. Authors: I. Lodding, C. Da-Cunha Bang, H. Sengeløv, M. Iversen, A. Rasmussen, L. Vindeløv, F. Gustafsson, N. Kirkby, A. Mocroft, S. Schwartz Sørensen, J. Lundgren on the behalf of the MATCH programme study group. 
 Monday 27th of April 15:15CET. abstract

 

First PERSIMUNE article
The first PERSIMUNE article is on the cover of PLoS Medicine "Development and Validation of a Risk Score for Chronic Kidney Disease in HIV infection Using Prospective Cohort Data from the D:A:D study"

An open access tool to calculate individual patient risk of chronic kidney disease was released in conjunction with the publication of the article 

Chairman’s poster prize for EuroSIDA poster
The poster: Rate of Accumulation of Drug Resistance Mutations during Virological Failure According to Different Measures of Viral Load Exposure was awarded the Chairman’s Poster Prize at the XXIV International Drug Resistance Workshop, 21-22 February, Seattle, Washington. See poster here 

Presentations from CROI 2015 now available online!

CHIP was represented at CROI 2015 with presentations from the EuroSIDA study, the D:A:D study and INSIGHT. Find them all HERE.

 

EuroSIDA at CROI 23rd-26th February 2015

EuroSIDA will be represented at the annual Conference on Retroviruses and Opportunistic Infections (CROI) with the following presentations: 

Posters:
"A Prognostic Score Estimating the Risk of Liver-Related Death Among HIV/HCV Coinfected Subjects", presented by Amanda Mocroft, submitting author: Daniel Grint. Session P-N1, February 24th 2.30-4.00 PM. Abstract number 637.

"New Marker of Standard-of-ART Care: Percentage of Time on cART With Suppressed HIV-RNA", presented by Kamilla Laut. Session P-K2, February 24th 2.30-4.00PM. Abstract number 561.

 

PERSIMUNE

DR News explains how PERSIMUNE and 60 million danish kroners will help determine why some people can't tolerate chemotherapy or organ transplantations article (in Danish)